Third-Generation Tyrosine Kinase Inhibitors and BeyondQUINTAS-CARDAMA, Alfonso; KANTARJIAN, Hagop; CORTES, Jorge et al.Seminars in hematology. 2010, Vol 47, Num 4, pp 371-380, issn 0037-1963, 10 p.Article

Molecular Pathways: Resistance to Kinase Inhibitors and Implications for Therapeutic StrategiesLOVLY, Christine M; SHAW, Alice T.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2249-2256, issn 1078-0432, 8 p.Article

Nilotinib: A Novel, Selective Tyrosine Kinase InhibitorBLAY, Jean-Yves; VON MEHREN, Margaret.Seminars in oncology. 2011, Vol 38, Num 2, issn 0093-7754, S3-S9, SUP1Article

NilotinibDEININGER, Michael W.Clinical cancer research. 2008, Vol 14, Num 13, pp 4027-4031, issn 1078-0432, 5 p.Article

The Evolving Field of Tyrosine Kinase Inhibitors in the Treatment of Endocrine TumorsLEI YE; SANTARPIA, Libero; GAGEL, Robert F et al.Endocrine reviews. 2010, Vol 31, Num 4, pp 578-599, issn 0163-769X, 22 p.Article

Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor ComplexBEEVERS, Christopher S; LONG CHEN; LEI LIU et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 3, pp 1000-1008, issn 0008-5472, 9 p.Article

Nilotinib. CommentariesROSTI, Gianantonio; LE COUTRE, Philipp.Drugs (Basel). 2008, Vol 68, Num 4, pp 460-461, issn 0012-6667, 2 p.Article

Bumped Kinase Inhibitor 1294 Treats Established Toxoplasma gondii InfectionSTONE DOGGETT, J; OJO, Kayode K; FAN, Erkang et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 6, pp 3547-3549, issn 0066-4804, 3 p.Article

Thyroid effects of tyrosine kinase inhibitorsILLOUZ, Frédéric; BRAUN, Doreen; BRIET, Claire et al.European journal of endocrinology. 2014, Vol 171, Num 3, issn 0804-4643, R91-R99Article

Dosage plasrnatique des inhibiteurs de tyrosine kinaseBOUCHET, S; POULETTE, S; MOLIMARD, M et al.Correspondances en onco-hématologie. 2009, Vol 4, Num 4, pp 177-178, issn 1954-4820, 2 p.Article

Playing Russian Roulette With Tyrosine Kinase InhibitorsSZMULEWITZ, R. Z; RATAIN, M. J.Clinical pharmacology and therapeutics. 2013, Vol 93, Num 3, pp 242-244, issn 0009-9236, 3 p.Article

Dasatinib enhances megakaryocyte differentiation but inhibits platelet formationMAZHARIAN, Alexandra; GHEVAERT, Cedric; LIN ZHANG et al.Blood. 2011, Vol 117, Num 19, pp 5198-5206, issn 0006-4971, 9 p.Article

Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation techniqueCHIRIO, Daniela; GALLARATE, Marina; PEIRA, Elena et al.Journal of microencapsulation. 2011, Vol 28, Num 6, pp 537-548, issn 0265-2048, 12 p.Article

Inhibition of Glycogen Synthase Kinase-3 Increases the Cytotoxicity of EnzastaurinROVEDO, Mark A; KRETT, Nancy L; ROSEN, Steven T et al.Journal of investigative dermatology. 2011, Vol 131, Num 7, pp 1442-1449, issn 0022-202X, 8 p.Article

The Phytoestrogen Genistein Is a Tissue-Specific Androgen Receptor ModulatorPIHLAJAMAA, Paivi; ZHANG, Fu-Ping; SAARINEN, Lilli et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 11, pp 4395-4405, issn 0013-7227, 11 p.Article

Curcumin-mediated lifespan extension in Caenorhabditis elegansHSIU-CHUAN LIAO, Vivian; YU, Chan-Wei; CHU, Yu-Ju et al.Mechanisms of ageing and development. 2011, Vol 132, Num 10, pp 480-487, issn 0047-6374, 8 p.Article

Curcumin Modulates Efflux Mediated by Yeast ABC Multidrug Transporters and Is Synergistic with AntifungalsSHARMA, Monika; MANOHARLAL, Raman; SHUKLA, Suneet et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 8, pp 3256-3265, issn 0066-4804, 10 p.Article

Tyrosine kinase inhibitors and modifications of thyroid function tests : a reviewILLOUZ, Frédéric; LABOUREAU-SOARES, Sandrine; DUBOIS, Séverine et al.European journal of endocrinology. 2009, Vol 160, Num 3, pp 331-336, issn 0804-4643, 6 p.Article

Practical Considerations for the Management of Patients in the Tyrosine Kinase Inhibitor EraO'DWYER, Michael; ATALLAH, Ehab.Seminars in hematology. 2009, Vol 46, Num 2, issn 0037-1963, S16-S21, SUP3Article

Metabolism and Disposition of Dasatinib after Oral Administration to HumansCHRISTOPHER, Lisa J; DONGHUI CUI; GALBRAITH, Susan et al.Drug metabolism and disposition. 2008, Vol 36, Num 7, pp 1357-1364, issn 0090-9556, 8 p.Article

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsBANTSCHEFF, Marcus; EBERHARD, Dirk; READER, Valérie et al.Nature biotechnology (Print). 2007, Vol 25, Num 9, pp 1035-1044, issn 1087-0156, 10 p.Article

Curcumin, a potential therapeutic candidate for retinal diseases : Curcumin: Recent Insights, Novel Developments, New ChallengesWANG, Lei-Lei; YUE SUN; KUN HUANG et al.Molecular nutrition & food research (Print). 2013, Vol 57, Num 9, pp 1557-1568, issn 1613-4125, 12 p.Article

New Perspectives of Curcumin in Cancer PreventionPARK, Wungki; RUHUL AMIN, A. R. M; GEORGIA CHEN, Zhuo et al.Cancer prevention research (Philadelphia, Pa.). 2013, Vol 6, Num 5, pp 387-400, issn 1940-6207, 14 p.Article

Sorafenib use while waiting for liver transplant: We still need to waitFINN, Richard S.Journal of hepatology. 2012, Vol 56, Num 3, pp 723-725, issn 0168-8278, 3 p.Article

Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors: Focus on 4-AnilinoquinazolinesSCHEFFLER, Matthias; DI GION, Paola; DOROSHYENKO, Oxana et al.Clinical pharmacokinetics. 2011, Vol 50, Num 6, pp 371-403, issn 0312-5963, 33 p.Article